Publications by authors named "Azim Jalali"

Claim this Profile
E
Exploring Real-World Outcomes of First Line EGFR Inhibitor Use, Cetuximab Versus Panitumumab, in Patients with Left-Sided, RAS Wild-Type, Metastatic Colorectal Cancer.
Jane McKenzie, Vanessa Wong, Shehara Mendis, Rachel Wong, Suzanne Kosmider, Azim Jalali

Clin Colorectal Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initial Assessment of Resectability of Colorectal Cancer Liver Metastases Versus Clinical Outcome.
Grace Y Kim, Azim Jalali, Grace Gard, Justin M Yeung, Hieu Chau

Clin Colorectal Cancer· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measuring quality in the care of metastatic colorectal cancer utilising available registry data: A modified Delphi study.
Catherine Dunn, Jeremy Shapiro, Margaret Lee, Rachel Wong, Belinda Lee, Azim Jalali

Eur J Cancer· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addressing disparities in health outcomes for patients with advanced pancreatic cancer and limited English proficiency.
Colin Williams, Geoff Chong, Mark Tacey, Frances Barnett, Jennifer Mooi, Azim Jalali

Asia Pac J Clin Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unified framework for patient-derived, tumor-organoid-based predictive testing of standard-of-care therapies in metastatic colorectal cancer.
Tao Tan, Dmitri Mouradov, Margaret Lee, Grace Gard, Yumiko Hirokawa, Azim Jalali

Cell Rep Med· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Compliance with Therapeutic Goods Association prescribing information: weekly or second weekly cetuximab for the treatment of metastatic colorectal cancer.
Matthew Loft, Jeremy Shapiro, Margaret Lee, Rachel Wong, Jeanne Tie, Azim Jalali

Intern Med J· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of the evolution in RAS mutation analysis in Australian patients with metastatic colorectal cancer.
Chia Yuen Chong, Azim Jalali, Hui Li Wong, Matthew Loft, Rachel Wong

Asia Pac J Clin Oncol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient demographics and management landscape of metastatic colorectal cancer in the third-line setting: Real-world data in an australian population.
Sandy Tun Min, Aflah Roohullah, Annette Tognela, Azim Jalali, Margaret Lee

Asia Pac J Clin Oncol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring Survival Outcomes in Metastatic Colorectal Cancer Harboring KRAS A146 Mutations: Important Distinction or Simple Distraction?
Richard Pham, Azim Jalali, Chia Chong, Vanessa Wong, Kate Dunn

JCO Precis Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use and outcomes of chemotherapy for metastatic pancreatic cancer in Australia.
Amy Body, Rachel Wong, Jeremy Shapiro, Azim Jalali, Sue-Anne McLachlan

Intern Med J· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biology and Clinical Implications of Fecal Occult Blood Test Screen-Detected Colorectal Cancer.
Shehara Mendis, Wei Hong, Sumitra Ananda, Ian Faragher, Ian Jones, Azim Jalali

JNCI Cancer Spectr· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment and Outcomes of Oligometastatic Colorectal Cancer Limited to Lymph Node Metastases.
Vinod Kalapurackal Mathai, Soe Yu Aung, Vanessa Wong, Catherine Dunn, Jeremy Shapiro, Azim Jalali

Clin Colorectal Cancer· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stage dependent recurrence patterns and post-recurrence outcomes in non-metastatic colon cancer.
Lucy Gately, Azim Jalali, Christine Semira, Ian Faragher, Matthew Croxford

Acta Oncol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating Tumour DNA as a Potential Cost-Effective Biomarker to Reduce Adjuvant Chemotherapy Overtreatment in Stage II Colorectal Cancer.
Yat Hang To, Koen Degeling, Suzanne Kosmider, Rachel Wong, Margaret Lee, Azim Jalali

Pharmacoeconomics· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Treatment and Outcomes of Metastatic Colorectal Cancer Patients With a Poor or Very Poor Performance Status.
Avraham Travers, Azim Jalali, Stephen Begbie, Christine Semira, Suzanne Kosmider

Clin Colorectal Cancer· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metastasectomy and BRAF mutation; an analysis of survival outcome in metastatic colorectal cancer.
Thiru Prasanna, Rachel Wong, Timothy Price, Jeremy Shapiro, Jeanne Tie, Azim Jalali

Curr Probl Cancer· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simulating Progression-Free and Overall Survival for First-Line Doublet Chemotherapy With or Without Bevacizumab in Metastatic Colorectal Cancer Patients Based on Real-World Registry Data.
Koen Degeling, Hui-Li Wong, Hendrik Koffijberg, Azim Jalali, Jeremy Shapiro

Pharmacoeconomics· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging strategies in the initial management of locally advanced rectal cancer.
Lucy Gately, Hui-Li Wong, Jeanne Tie, Rachel Wong, Margaret Lee, Azim Jalali

Future Oncol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective analysis of 30-day mortality following palliative chemotherapy at a tertiary cancer centre.
James A McCracken, Adrian Dabscheck, Maria Coperchini, Ilana Hornung, Azim Jalali

Cancer Rep (Hoboken)· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hodgkin lymphoma: an Australian experience of ABVD chemotherapy in the modern era.
Azim Jalali, Francis J Ha, Geoff Chong, Andrew Grigg, Joe Mckendrick

Ann Hematol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis